News

 

For additional media information, contact:
Arthur J. Shannon, Vice President, Investor Relations and Communication
ajshannon@perrigo.com
269-686-1709(direct)
269-673-9128 (fax)

Ernest J. Schenk, Manager, Investor Relations and Communication
eschenk@perrigo.com
269-673-9212 (direct)
269-673-9128 (fax)

 

Archive: 2007 |2006  | 2005  |  2004  |  2003 |  2002

2008

Perrigo Presentation Slides for 12th Annual Sidoti Emerging Growth Institutional Investor Forum
March 25, 2008
See Attachment

Perrigo to Present at the 12th Annual Sidoti Emerging Growth Institutional Investors Forum
March 24, 2008
See Attachment

Perrigo Announces Launch of Clobetasol Propionate Foam
March 20, 2008
See Attachment

Perrigo Receives Final Approval on Clobetasol Propionate Foam; Court Issues Temporary Restraining Order
March 11, 2008
See Attachment

Perrigo To Market OTC Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
March 6, 2008
See Attachment

Perrigo Announces Initial Shipments of Store Brand Omeprazole Tablets
March 4, 2008
See Attachment

Perrigo Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
February 12, 2008
See Attachment

Perrigo Presentation Slides for Merrill Lynch Global Pharma Biotechnology and Medical Devide Conf
February 5, 2008
See Attachment

Perrigo to Present at Merrill Lynch Global Pharma Biotechnology and Medical Devide Conference
February 5, 2008
See Attachment

Perrigo Reports Record Sales and Earnings for Q2 Fiscal 2008; Increases Full Year Guidance
February 5, 2008
See Attachment

Perrigo Authorizes Continuation of Share Repurchase; Announces Quarterly Dividend
February 1, 2008
See Attachment

Perrigo Will Release Second Quarter Fiscal 2008 Results on February 5, 2008
Janauary 22, 2008
See Attachment

Perrigo's Presentation Slides at the 26th Annual JPMorgan Healthcare Conference
January 9, 2008
See Attachment

Perrigo Acquires UK OTC Store Brand Supplier
January 9, 2008
See Attachment

Perrigo to Present at the 26th Annual JPMorgan Healthcare Conference
January 4, 2008
See Attachment